@article {Griesberger541, author = {Martina Griesberger and Alexander Kollau and Gerald W{\"o}lkart and M. Verena Wenzl and Matteo Beretta and Michael Russwurm and Doris Koesling and Kurt Schmidt and Antonius C. F. Gorren and Bernd Mayer}, title = {Bioactivation of Pentaerythrityl Tetranitrate by Mitochondrial Aldehyde Dehydrogenase}, volume = {79}, number = {3}, pages = {541--548}, year = {2011}, doi = {10.1124/mol.110.069138}, publisher = {American Society for Pharmacology and Experimental Therapeutics}, abstract = {Mitochondrial aldehyde dehydrogenase (ALDH2) contributes to vascular bioactivation of the antianginal drugs nitroglycerin (GTN) and pentaerythrityl tetranitrate (PETN), resulting in cGMP-mediated vasodilation. Although continuous treatment with GTN results in the loss of efficacy that is presumably caused by inactivation of ALDH2, PETN does not induce vascular tolerance. To clarify the mechanisms underlying the distinct pharmacological profiles of GTN and PETN, bioactivation of the nitrates was studied with aortas isolated from ALDH2-deficient and nitrate-tolerant mice, isolated mitochondria, and purified ALDH2. Pharmacological inhibition or gene deletion of ALDH2 attenuated vasodilation to both GTN and PETN to virtually the same degree as long-term treatment with GTN, whereas treatment with PETN did not cause tolerance. Purified ALDH2 catalyzed bioactivation of PETN, assayed as activation of soluble guanylate cyclase (sGC) and formation of nitric oxide (NO). The EC50 value of PETN for sGC activation was 2.2 {\textpm} 0.5 μM. Denitration of PETN to pentaerythrityl trinitrate was catalyzed by ALDH2 with a specific activity of 9.6 {\textpm} 0.8 nmol {\textperiodcentered} min-1 {\textperiodcentered} mg-1 and a very low apparent affinity of 94.7 {\textpm} 7.4 μM. In contrast to GTN, PETN did not cause significant inactivation of ALDH2. Our data suggest that ALDH2 catalyzes bioconversion of PETN in two distinct reactions. Besides the major denitration pathway, which occurs only at high PETN concentrations, a minor high-affinity pathway may reflect vascular bioactivation of the nitrate yielding NO. The very low rate of ALDH2 inactivation, presumably as a result of low affinity of the denitration pathway, may at least partially explain why PETN does not induce vascular tolerance.}, issn = {0026-895X}, URL = {https://molpharm.aspetjournals.org/content/79/3/541}, eprint = {https://molpharm.aspetjournals.org/content/79/3/541.full.pdf}, journal = {Molecular Pharmacology} }